Related Experiment Video
Updated: May 11, 2026
09:39
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
Intravenous needle-free injection devices: new information for compounding pharmacists
Denise Macklin1, Paul L Blackburn
1RyMed Technologies Inc, Franklin, TN, USA.
International Journal of Pharmaceutical Compounding
|May 23, 2013
Summary
Compounding pharmacists can prevent healthcare worker injuries and improve patient outcomes by educating clients on needle-free intravenous medication devices. This promotes safer practices and reduces risks associated with traditional needles.
Area of Science:
- Pharmacy Practice
- Patient Safety
- Infection Control
Background:
- Percutaneous needle-stick injuries pose significant risks to healthcare workers, including emotional distress, morbidity, and potential mortality.
- An estimated 385,000 sharps-related injuries occur annually in hospitals alone, with over 50% of occupational percutaneous injuries going unreported.
- Sharps injuries are linked to the transmission of over 20 pathogens, such as Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus.
Purpose of the Study:
- To highlight the critical role of compounding pharmacists in promoting the adoption of needle-free intravenous medication devices.
- To educate healthcare professionals on the advantages and types of available needle-free technologies.
- To reduce complications associated with vascular access devices and prevent needlestick injuries.
Main Methods:
- Review of available intravenous needle-free devices relevant to compounding pharmacists and their clients.
- Explanation of the design features and capabilities of needle-free equipment.
- Addressing frequently asked questions regarding the use of needle-free devices.
Main Results:
- Needle-free devices offer a safer alternative for intravenous medication administration compared to traditional needles.
- Educating healthcare providers on needle-free technology can enhance treatment outcomes.
- Increased understanding and utilization of needle-free devices can protect healthcare workers from needlestick injuries.
Conclusions:
- Compounding pharmacists are pivotal in advocating for and educating on needle-free intravenous medication systems.
- The adoption of needle-free devices is essential for improving patient safety and protecting healthcare personnel.
- Informed use of needle-free technology by pharmacists and caregivers leads to better treatment results and a safer healthcare environment.
Related Concept Videos
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
00:59Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
01:25Routes of Drug Administration: Parenteral
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...